课题基金 / 基金详情

项目摘要

项目成果

ERIK L HEWLETT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pertussis is a major cause of childhood morbidity in the developing world and as a result of concerns about pertussis vaccine reactogenicity, has increased in incidence in many areas of the developed world. Pertussis toxin (PT), a major virulence factor of Bordetella pertussis, elicits a variety of effects including lymphocytosis, sensitization to histamine, and enhancement of insulin secretion. Intriguingly, the B or binding component of PT (B-oligomer), which delivers its active portion to target cells, has biological effects of its own, namely calcium mobilization followed by lymphocyte proliferation and platelet aggregation. These actions, which are poorly understood, are independent of the ADP-ribosylation of G- proteins by which PT has the majority of its known effects. Acquisition of more information is important because many acellular pertussis vaccines contain PT in which holotoxin activities are eliminated, but B-oligomer effects are present or enhanced. In this proposal, different preparations of B-oligomer and holotoxin will be evaluated for potency in eliciting B- oligomer effects (lymphocyte proliferation and platelet activation). The second messenger systems involved will be explored and a screen of other cell types will be made for responses to B-oligomer. The receptor for B- oligomer action will be identified and the structural requirements for B- oligomer to elicit its effects will be studied with toxins containing mutations at specific sites. Finally, the relationship between B-oligomer mobilization of calcium and the subsequent intoxication of a target cell by ADP-ribosylation will be investigated. The resultant data will provide a perspective on using B-oligomer as a research tool and will guide its use as an antigen in acellular pertussis vaccine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
11th International Symposium on Bordetella
  • 批准号:
    9053803
  • 项目类别:
  • 资助金额:
    $0.5万
  • 财政年份:
    2016
  • 负责人:
    ERIK L HEWLETT
  • 依托单位:
Integrated analysis of cellular responses to toxins from clostridium difficile
  • 批准号:
    8233381
  • 项目类别:
  • 资助金额:
    $32.89万
  • 财政年份:
    2011
  • 负责人:
    ERIK L HEWLETT
  • 依托单位:
Bordetella cyclase toxin: effects on leukocytes and respiratory epithelial cells
  • 批准号:
    7846692
  • 项目类别:
  • 资助金额:
    $3.22万
  • 财政年份:
    2009
  • 负责人:
    ERIK L HEWLETT
  • 依托单位:
Integrated analysis of cellular responses to toxins from clostridium difficile
  • 批准号:
    7670083
  • 项目类别:
  • 资助金额:
    $32.26万
  • 财政年份:
    2009
  • 负责人:
    ERIK L HEWLETT
  • 依托单位:
海外基金